However, our group showed that the protective effect of these shorter pulses on osteonecrosis development may be dependent on the therapeutic context and especially that the administration of concurrent intensified asparaginase (administered in current ALL protocols) could attenuate the benefit8. This evidence concerns the gene ASPG and osteonecrosis.